SCHEMBL1691506

SCHEMBL1691506

OCc1c(-c2ccc(F)cc2)nc2ccccn12

nearest known ligand 0.58

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.58
KDM4E B2RXH2 5/20 0.55
HPGD P15428 1/20 0.55
KCNK3 O14649 8/20 0.54
KCNK9 Q9NPC2 8/20 0.54
NPC1 O15118 1/20 0.51
POLB P06746 1/20 0.51
HTT P42858 1/20 0.51
RAB9A P51151 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
GABRA1 P14867 1/20 0.48
GABRB2 P47870 1/20 0.48
FLT3 P36888 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1691661 0.85 KDM4E (0.69) KDM4EKCNK3KCNK9NPC1POLB
SCHEMBL1691474 0.85 ALDH1A1 (0.58) ALDH1A1KDM4EKCNK3KCNK9NPC1
Hydrochloric Acid SCHEMBL1430012 0.84 ALDH1A1 (0.57) ALDH1A1KDM4EHPGDKCNK3KCNK9
SCHEMBL2198214 0.82 ALDH1A1 (0.54) ALDH1A1KDM4EHPGDKCNK3KCNK9
SCHEMBL18963128 0.82 KDM4E (0.57) KDM4EKCNK3KCNK9NPC1POLB
SCHEMBL1691664 0.80 PTGS2 (0.54) KDM4ENPC1POLBHTTRAB9A
SCHEMBL13341899 0.79 NPC1 (0.55) ALDH1A1KDM4EHPGDNPC1POLB
SCHEMBL1431645 0.78 KCNK3 (0.50) ALDH1A1KDM4EHPGDKCNK3KCNK9
SCHEMBL7894902 0.77 AKT1 (0.40) ALDH1A1KDM4EHPGDKCNK3KCNK9
SCHEMBL1691303 0.77 GABRA1 (0.68) ALDH1A1KDM4EHPGDPOLBHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2376490-B1 IMIDAZOPYRIDINE COMPOUNDS PROXIMAGEN LTD (GB) 2013-01-23 EP claimed
US-20120010188-A1 Imidazopyridine Compounds PROMIMAGEN LTD. (GB) 2012-01-12 US claimed
EP-2376490-A1 IMIDAZOPYRIDINE COMPOUNDS Proximagen Limited (GB) 2011-10-19 EP claimed
WO-2010064020-A1 IMIDAZOPYRIDINE COMPOUNDS PROXIMAGEN LTD. (GB) 2010-06-10 WO claimed
US-20150239905-A1 IMIDAZOPYRIDINE COMPOUNDS BIOVITRUM AB (PUBL) (SE) 2015-08-27 US disclosed
US-20140206662-A1 Imidazopyridine Compounds PROXIMAGEN LTD. (GB) 2014-07-24 US disclosed
EP-2393804-B1 NOVEL SUBSTITUTED BICYCLIC HETEROCYCLIC COMPOUNDS AS GAMMA SECRETASE MODULATORS JANSSEN PHARMACEUTICALS INC (US) 2014-04-16 EP disclosed
EP-2376490-B1 IMIDAZOPYRIDINE COMPOUNDS PROXIMAGEN LTD (GB) 2013-01-23 EP disclosed
US-20120010188-A1 Imidazopyridine Compounds PROMIMAGEN LTD. (GB) 2012-01-12 US disclosed
EP-2376490-A1 IMIDAZOPYRIDINE COMPOUNDS Proximagen Limited (GB) 2011-10-19 EP disclosed
WO-2010064020-A1 IMIDAZOPYRIDINE COMPOUNDS PROXIMAGEN LTD. (GB) 2010-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010188-A1 Imidazopyridine Compounds SSB, MIF, IDO1 ALDH1A1 65/4885KDM4E 2671/4885HPGD 112/4885
US-20150239905-A1 IMIDAZOPYRIDINE COMPOUNDS SSB, MIF, IDO1 ALDH1A1 65/4885KDM4E 2671/4885HPGD 112/4885
US-20140206662-A1 Imidazopyridine Compounds SSB, NFKBIA, TPMT ALDH1A1 192/4885KDM4E 2821/4885HPGD 311/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.